Niels Svenstrup

Corporate Officer/Principal at PEPGEN INC.

Net worth: - $ as of 31/05/2024

54 year

Health Technology

Consumer Services

Profile

Niels Svenstrup is currently the SVP-Chemistry, Manufacturing & Control at PepGen Inc. Prior to this, he was the Senior Vice President-Development at Cydan II, Inc. from 2017 to 2021.
He was also the Director-CMC at Ascendis Pharma A from 2015 to 2017 and the Head-Medicinal Chemistry Department at H.
Lundbeck A from 2008 to 2015.
Dr. Svenstrup holds a graduate and doctorate degree from the University of Southern Denmark.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
PEPGEN INC. -.--%	17/05/2024	0 ( -.--% )	- $	31/05/2024

Niels Svenstrup active positions

Companies	Position	Start
PEPGEN INC.	Corporate Officer/Principal	01/04/2021

All active positions of Niels Svenstrup

Former positions of Niels Svenstrup

Companies	Position	End
Cydan II, Inc. Cydan II, Inc. Pharmaceuticals: GenericHealth Technology Cydan II, Inc. develops and commercializes drugs for orphan and diseases. The firm evaluates products for treating rare diseases with high unmet medical need to start multiple companies to develop such therapies. The company was founded by Cristina Csimma, James G. McArthur, Deborah S. Geraghty and Christoph M. Adams in 2013 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	01/04/2021
ASCENDIS PHARMA A/S	Corporate Officer/Principal	01/07/2017
H. LUNDBECK A/S	Corporate Officer/Principal	01/11/2015

See the detail of Niels Svenstrup's experience

Training of Niels Svenstrup

University of Southern Denmark

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Niels Svenstrup's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
PEPGEN INC.	Health Technology
ASCENDIS PHARMA A/S	Health Technology
H. LUNDBECK A/S	Health Technology

Private companies	1
Cydan II, Inc. Cydan II, Inc. Pharmaceuticals: GenericHealth Technology Cydan II, Inc. develops and commercializes drugs for orphan and diseases. The firm evaluates products for treating rare diseases with high unmet medical need to start multiple companies to develop such therapies. The company was founded by Cristina Csimma, James G. McArthur, Deborah S. Geraghty and Christoph M. Adams in 2013 and is headquartered in Cambridge, MA.	Health Technology